---
title: Select Publications
---

# üìö Select Publications

This is an assortment of scientific articles authored or co-authored by our team members, covering **real-world evidence** in **amyotrophic lateral sclerosis (ALS)** and other disease areas. 

---
## 2025
- **The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and aging**  
  Imam F, Saloner R, Vogel JW, Krish V, Abdel-Azim G, Ali M, An L, Anastasi F, Bennett D, Pichet Binette A, Boxer AL, Bringmann M, Burns JM, Cruchaga C, Dage JL, Farinas A, Ferrucci L, Finney CA, Frasier M, Hansson O, Hohman TJ, Johnson ECB, Kivimaki M, Korologou-Linden R, Ruiz Laza A, Levey AI, Liepelt-Scarfone I, Lu L, Mattsson-Carlgren N, Middleton LT, Nho K, Oh HS, Petersen RC, Reiman EM, Robinson O, Rothstein JD, Saykin AJ, Shvetcov A, Slawson C, Smets B, Su√°rez-Calvet M, Tijms BM, Timmers M, Vieira F, Vilor-Tejedor N, Visser PJ, Walker KA, Winchester LM, Wyss-Coray T, Yang C, Bose N, Lovestone S; Global Neurodegeneration Proteomics Consortium (GNPC). *Nature Medicine*. 2025 Jul 15. doi:[10.1038/s41591-025-03834-0](https://doi.org/10.1038/s41591-025-03834-0). [PMID: 40665048](https://pubmed.ncbi.nlm.nih.gov/40665048/)

- **Wrangling Real-World Data: Optimizing Clinical Research Through Factor Selection with LASSO Regression**  
  Howard KA, Anderson W, Podichetty JT, Gould R, Boyce D, Dasher P, Evans L, Kao C, Kumar VK, Hamilton C, Math√© E, Guerin PJ, Dodd K, Mehta AK, Ortman C, Patil N, Rhodes J, Robinson M, Stone H, & Heavner SF. *International Journal of Environmental Research and Public Health*. 2025;22(4):464. doi:[10.3390/ijerph22040464](https://doi.org/10.3390/ijerph22040464). [Full text](https://www.mdpi.com/1660-4601/22/4/464)

- **Large language models and clinical calculations: to err is human and machines are not exempt**  
  Kilpatrick R, Greenberg RG, Boyce D, et al. *Pediatric Research*. 2025. doi:[10.1038/s41390-025-04166-y](https://doi.org/10.1038/s41390-025-04166-y). [Full text](https://www.nature.com/articles/s41390-025-04166-y)

---
## 2024
- **Free-living monitoring of ALS progression in upper limbs using wearable accelerometers**  
  Straczkiewicz M, Burke KM, Calcagno N, et al. *Journal of NeuroEngineering and Rehabilitation*. 2024;21:223. doi:[10.1186/s12984-024-01514-7](https://doi.org/10.1186/s12984-024-01514-7). [Full text](https://link.springer.com/article/10.1186/s12984-024-01514-7)

- **Big data research is everyone's research‚ÄîMaking epilepsy data science accessible to the global community: Report of the ILAE big data commission**  
  Josephson CB, Aronica E, Beniczky S, Boyce D, Cavalleri G, Denaxas S, French J, Jehi L, Koh H, Kwan P, McDonald C, Mitchell JW, Rampp S, Sadleir L, Sisodiya SM, Wang I, Wiebe S, Yasuda C, Youngerman B; the ILAE Big Data Commission. *Epilepsia Open*. First published: 24 Oct 2024. doi:[10.1002/epd2.20288](https://doi.org/10.1002/epd2.20288)

- **Real-world use of the updated refractory epilepsy screening tool for Lennox‚ÄìGastaut syndrome**  
  Wolf SM, Boyce D, Pe√±a P, Pi√±a-Garza JE, Roland JJ, Thomas B, Zogejani D, McGoldrick PE. *Epilepsia Open*. First published: 10 May 2024. doi:[10.1002/epi4.12952](https://doi.org/10.1002/epi4.12952)

- **What do you think caused your ALS? An analysis of the CDC national amyotrophic lateral sclerosis patient registry qualitative risk factor data using artificial intelligence and qualitative methodology**  
  Boyce D, Raymond J, Larson TC, Kirkland E, Horton DK, Mehta P. *Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration*. 2024;25(5‚Äì6):615‚Äì624. doi:[10.1080/21678421.2024.2349920](https://doi.org/10.1080/21678421.2024.2349920). [Full text](https://www.tandfonline.com/doi/full/10.1080/21678421.2024.2349920)

---
## 2023
- **Consumer-grade wearables and machine learning sensitively capture disease progression in amyotrophic lateral sclerosis**  
  Gupta AS, Patel S, Premasiri A, Vieira F. *medRxiv*. 2023. doi:[10.1101/2023.03.28.23287869](https://doi.org/10.1101/2023.03.28.23287869). [Preprint](https://www.medrxiv.org/content/10.1101/2023.03.28.23287869v1)

---
## 2022
- **A machine-learning based objective measure for ALS disease severity**  
  Vieira FG, Venugopalan S, Premasiri AS, et al. *npj Digital Medicine*. 2022;5:45. doi:[10.1038/s41746-022-00588-8](https://doi.org/10.1038/s41746-022-00588-8). [Full text](https://www.nature.com/articles/s41746-022-00588-8)

  ---

## üîó Related Work

- **STARDUSTT Approach** ‚Äî A practical white paper on addressing the ‚Äúcurse of knowledge‚Äù in OMOP implementations with the STARDUSTT framework.  
  *Read:* [STARDUSTT Approach](stardustt-approach.md)

- **Free RWE Resources** ‚Äî Open learning materials, tutorials, and examples for building real-world evidence workflows authored or co-authored by our team members.  
  *Read:* [Free RWE Resources](free-rwe-resources.md)

